Exicure stock falls 2.24 percent with Nasdaq deadline ahead
Published on 09/25/2026 at 15:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Exicure stock fell 2.24 percent to USD 1.20 on Nasdaq on September 25, 2026, giving the biotechnology company a market value of USD 7,664,659. The key date is December 2, 2026, when Exicure must demonstrate compliance with Nasdaq's minimum equity rule.
Nasdaq sets a December deadline
According to Yahoo Finance on September 16, 2026, Nasdaq granted Exicure an extension after the company received its listing letter on September 10, 2026. The requirement under Listing Rule 5550(b)(1) is at least USD 2.5 million in stockholders' equity.
The extension gives Exicure time to complete compliance initiatives and publicly demonstrate that it meets the requirement by December 2, 2026. Stock Titan reports that Nasdaq will continue monitoring the company through its next periodic report, with a potential delisting determination if the terms are not met.
Q2 loss narrows as revenue stays at zero
For the three months ended June 30, 2026, Exicure reported revenue of USD 0, a net loss of USD 1.1 million and diluted EPS of USD -0.18. The Desperate Trader lists the year-ago net loss at USD 2.6 million, making the latest loss smaller by USD 1.5 million.
The same Q2 snapshot lists cash on hand at USD 1.7 million. That figure is below the USD 2.5 million stockholders' equity threshold Nasdaq requires, although cash and equity are different balance-sheet measures.
Stock remains near its yearly low
At USD 1.20 on September 25, 2026 at 9:38 a.m. ET, XCUR stood USD 0.15 above its 52-week low of USD 1.05 and USD 8.28 below its 52-week high of USD 9.48. The stock's current valuation therefore sits much closer to the lower end of its annual range.
Exicure market and company data
- Company: Exicure, Inc.
- Ticker: XCUR
- Trading venue: Nasdaq
- Price (as of September 25, 2026, 9:38 a.m. ET): USD 1.20
- Market capitalization: USD 7,664,659 as of September 25, 2026
- 52-week range: USD 1.05-9.48 as of September 25, 2026
- Sector / Industry: Healthcare / Biotechnology
